Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 2, 2002, Pages 446-452

  Marston, Eric L ^a   James, Andrea V ^a   Parker, J Todd ^a   Hart, John C ^a   Brown, Teresa M ^a   Messmer, Trudy O ^a   Jue, Danny L ^a   Black, Carolyn M ^a   Carlone, George M ^a   Ades, Edwin W ^a   Sampson, Jacquelyn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOREACTIVITY; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE DATABASE; SPECIES DIFFERENCE; STANDARDIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; BACTERIAL VACCINES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY;

EID: 0036129502     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.2.446-452.2002     Document Type: Article

References (52)

1. Chlamydia pneumoniae strain TWAR infection in Seattle children and their families 1965-79
2. Laboratory diagnosis of human chlamydial infections
3. Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens
4. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide
5. Infection with Chlamydia pneumoniae in Brooklyn
6. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
7. Molecular biology of the Chlamydia pneumoniae surface
8. Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine
9. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella
10. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: A potential link to accelerated arteriosclerosis
11. Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation
12. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms
13. Growth in vascular cells and cytokine production by Chlamydia pneumoniae
14. Evidence of 2 waves of Chlamydia pneumoniae infection in Gavle, Sweden, 1990-96
15. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
16. Chlamydia pneumoniae (TWAR) infections in children
17. Infections caused by Chlamydia pneumoniae strain TWAR
18. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
19. Community and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically
20. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases
21. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library
22. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland
23. Chlamydia infection and pneumonia
24. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
25. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
26. Chlamydia pneumoniae facilitates monocyte adhesion to endothelial and smooth muscle cells
27. Methods for reducing non-specific antibody binding in enzyme-linked immunosorbent assays
28. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity
29. Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae
30. Mimotopes: Realization of an unlikely concept
31. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae
32. An immunogenic epitope of Chlamydia pneumoniae from a random phage display peptide library is reactive with both monoclonal antibody and patients sera
33. Prevalence of Chlamydia pneumoniae in acute lower respiratory infection in the pediatric population in Japan
34. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections
35. Antibody-selectable filamentous fd phage vectors: Affinity purification of target genes
36. Purification, partial characterization, and seroreactivity of a genuswide 60-kilodalton Legionella protein antigen
37. PCR protocols for emerging infectious diseases
38. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics
39. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen
40. The epidemiology of community-acquired pneumonia among hospitalized adults
41. Incidence of lower respiratory tract infections caused by Mycoplasma, Chlamydia and Legionella: An Italian multicenter survey
42. Libraries of peptides and proteins displayed on filamentous phage
43. Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library
44. Evidence for Chlamydia pneumoniae of non-human origin
45. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA
46. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
47. Microimmunofluorescence serological studies with the TWAR organism
48. Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody
49. Improved fusion technique. II. Stability and purity of hybrid clones
50. Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract
51. The species specificity of the microimmunofluorescence antibody test anc comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae
52. Etiology and treatment of community-acquired pneumonia in ambulatory children